Omidubicel-onlv
Details of the Drug
- Generic Name:
- Omidubicel-onlv
- Drug Type:
- Nicotinamide modified allogeneic hematopoietic progenitor cell therapy derived from cord blood
- How the Drug is Given:
Intravenous
- Names:
- Omidubicel-onlv
- Omisirge®
Indications and Usage
Oomidubicel-onlv is indicated for use in adults and pediatric patients 12 years and older with hematologic malignancies who are planned for umbilical cord blood transplantation following myeloablative conditioning to reduce the time to neutrophil recovery and the incidence of infection.
Side effects needing medical attention
The most common adverse reactions are infections, GvHD, and infusion reaction.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.